[Double blind studies on 2-sulfanilamido-5-methoxy-pyrimidine (Durenat or Bayrena) in chronic bronchopulmonary diseases].
D001986:Bronchial Spasm / Q000150:complications; D001987:Bronchiectasis / Q000150:complications; D001991:Bronchitis / Q000188:drug therapy*; D002908:Chronic Disease; D002986:Clinical Trials as Topic; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D010919:Placebos; D011656:Pulmonary Emphysema / Q000517:prevention & control; D013147:Spirometry; D013449:Sulfonamides / Q000627:therapeutic use*; D013997:Time Factors
D010919:Placebos; D013449:Sulfonamides
Doppelblinduntersuchungen mit 2-Sulfanilamido-5-methoxy-pyrimidin (Durenat bzw. Bayrena) bei chronischen bronchopulmonalen Erkrankungen.